The long-term T2D remission in this study was associated with a shorter duration of diabetes, lower preoperative fasting glucose and HbA1c, and less use of insulin therapy before surgery, which are known to be associated with a greater β-cell pancreatic function reserve. The gene discussed is INS; the disease is type 2 diabetes mellitus.